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Biofilms are structurally complex microconsortia of surface adhering cells embedded within 
an extracellular matrix (ECM) composed of substances produced and secreted by cells or 
derived from cell lysis. One of the recently discovered bacterial biofilms ECM components is 
the extracellular DNA (eDNA). Although the investigation on eDNA in fungal biofilms is 
scarce, preliminary studies suggest that eDNA may play a role in biofilms formed by the 
opportunistic fungal pathogen Candida albicans. Thus, the present study aimed at 
determining the eDNA content of C. albicans SC5314 biofilm ECM and the effect of DNase I 
treatment on biofilm formation and biofilm cells susceptibility to antifungals, as indicators of 
the role of eDNA in C. albicans biofilms. 
Results from our experiments showed that the ECM of C. albicans biofilms formed under 
conditions of flow for 48 h contained 3045.4 ± 227.3 ng eDNA/mg of protein. Additionally, 
using a microtiter plate model, we observed that different DNase treatments (0.02 - 2 mg/ml) 
did not affect further biofilm development by C. albicans adherent cells. However, DNase (> 
0.03 mg/ml) promoted a general biomass reduction on C. albicans preformed biofilms. 
Finally, DNase (0.13 mg/ml) did not change C. albicans biofilm cells susceptibility to 
fluconazole, but increased their susceptibility to amphotericin B and caspofungin, as 
indicated by the lower SMIC compared to biofilms grown without DNase. 
This work presents evidence for the role of eDNA in C. albicans biofilm integrity and 
antifungal resistance consistent with eDNA being a key element of the ECM. 
